EUVIMEDEUVIMED entdecken
Crossref

A Multifunctional Enzyme Cascade Catalytic Nanoplatform for Effective Synergistic Therapy of Rheumatoid Arthritis

Wenyan Yu, Xinyun Wu, Ming Li, Liya Mu, Yan Ma, Man Liu, Zhe Chen, Yage Luo, Jinjin Shi, Jitian Li

Advanced Functional Materials · 2025-08 · 35 (35)

DOI: 10.1002/adfm.202423054 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Functional Materials, online erschienen am 23.03.2025. Verfasst von Wenyan Yu und 9 weiteren Autor:innen. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 46 Literaturangaben. Gefördert von: National Natural Science Foundation of China, National Key Research and Development Program of China.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Insufficient oxygen supply and elevated levels of reactive oxygen species (ROS) in rheumatoid arthritis (RA) joints synergistically exacerbate inflammation and accelerate disease progression. In this study, a hybrid nanoassembly composed of superoxide dismutase (SOD) and catalase (CAT) conjugated within a single poly(ε‐caprolactone) (PCL) nanoparticle is developed for RA therapy. The synthesized nanoassembly (PSC) drives a proximity‐dependent cascade reaction that efficiently scavenges ROS and generates oxygen, thereby modulating the phenotype of inflammatory macrophages in RA synovium, significantly inhibiting the secretion of pro‐inflammatory cytokines, and consequently alleviating inflammation. Furthermore, PSC functions as a versatile drug delivery platform for hydrophobic small‐molecule drugs. Iguratimod (IGU), an anti‐rheumatic drug with bone‐protective properties, is incorporated into the PSC (PSC@IGU), which is then loaded into dissolvable microneedles (MNs) to enhance drug delivery efficiency. Finally, PSC@IGU MNs demonstrate significant therapeutic effects in RA mouse models by effectively improving joint hypoxia, alleviating synovial inflammation, and preventing bone erosion. This study highlights the potential of PSC@IGU‐loaded MNs for the treatment of RA, indicating their promising ability to bridge basic research with clinical translation.

Förderung

  • National Natural Science Foundation of China
  • National Key Research and Development Program of China

Zitieren

APA

Yu, W., Wu, X., Li, M., Mu, L., Ma, Y., Liu, M., Chen, Z., Luo, Y., Shi, J., & Li, J. (2025). A Multifunctional Enzyme Cascade Catalytic Nanoplatform for Effective Synergistic Therapy of Rheumatoid Arthritis. Advanced Functional Materials, 35(35). https://doi.org/10.1002/adfm.202423054

Vancouver

Yu W, Wu X, Li M, Mu L, Ma Y, Liu M, et al. A Multifunctional Enzyme Cascade Catalytic Nanoplatform for Effective Synergistic Therapy of Rheumatoid Arthritis. Advanced Functional Materials. 2025;35(35). doi:10.1002/adfm.202423054

BibTeX
@article{Yu2025,
  author = {Yu, Wenyan and Wu, Xinyun and Li, Ming and Mu, Liya and Ma, Yan and Liu, Man and Chen, Zhe and Luo, Yage and Shi, Jinjin and Li, Jitian},
  title = {A Multifunctional Enzyme Cascade Catalytic Nanoplatform for Effective Synergistic Therapy of Rheumatoid Arthritis},
  journal = {Advanced Functional Materials},
  year = {2025},
  volume = {35},
  number = {35},
  doi = {10.1002/adfm.202423054}
}
Kostenlos starten →